Galapagos NV Catalyst Calendar

Proactively evaluate Galapagos NV’s catalyst impacts to stay ahead of the competition & improve corporate planning. Bolster business development with timely opportunities.

A sample of Galapagos NV Catalyst Calendar data

Event Date Event Type Company Name Ticker Symbol Drug Name Therapy Area Indication Source Type
Showing 3 of 110+ results. Subscribe to unlock more.
01 Nov 2019 GDCTXXXX Lorem Lorem Lorem XXXX Planned Lorem
01 Nov 2019 Phase III Trial Initiation Galapagos NV; Gilead Sciences Inc GILD; GLPG filgotinib maleate Immunology; Musculoskeletal Disorders Plaque Psoriasis (Psoriasis Vulgaris); Psoriasis; Psoriatic Arthritis Clinical Trial Registry
01 Nov 2019 Phase I Trial Completion Galapagos NV GLPG aldumastat Musculoskeletal Disorders Osteoarthritis Clinical Trial Registry
30 Sep 2019 Phase II Trial Results Galapagos NV; Gilead Sciences Inc; ICON Plc GILD; GLPG; ICLR filgotinib maleate; lanraplenib succinate Immunology Cutaneous Lupus Erythematosus Company Presentation
Catalyst Calendar

Feature

Catalyst Calendar provides forecasted drug development milestones within the Pharma industry including expected timing, expected outcomes and possible financial impacts.

Benefit

Access:

  • Trial Events for trials conducted globally by a company, university, institute or CRO:  Trial Initiation, Trial Completion, Trial Results
  • Regulatory Events related to drug filings with regulatory bodies, approvals and commercial launches. This is covered for the US, EU and Japan
  • Intellectual Property Events for patent and exclusivity expiry specific to the US, EU and Japan: Constraining Patent Expiry (US/EU/Japan), Drug Expiry (US/EU/Japan), Commercial Launch (US/EU/Japan)

Value

Proactively evaluate companies and catalyst impacts

Stay ahead of the competition & improve corporate planning

Bolster business development with timely opportunities

Premium databases is part of our industry range of products

Subscribe to Company Analytics & gain 12-month access to premium industry data & analytics
Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.

Explorer

Access more premium companies when you subscribe to Explorer